What you carry at this position in your DNA and what research says about it.
Nicotine and Lung Risk: 9/10 evidence, 69 publications.
You're viewing every possible genotype for this variant.
None of these is your result. Use the genotype toggle to compare them, then sign up and upload your DNA to see which one is yours.
Sample genotype (not yours): G/G
Typical Nicotine Dependence and Lung Cancer Risk
A pair of common G alleles is associated with typical nicotine sensitivity and a standard baseline risk for smoking-related lung conditions. If you smoke, you are likely to smoke fewer cigarettes per day compared to those with the A allele.
What this genotype means: Typical sensitivity to nicotine; Lower average cigarettes smoked per day if a smoker; Standard baseline risk for lung cancer and PAD.
Sample genotype (not yours): A/A
Significantly Increased Nicotine Dependence and Lung Cancer Risk
Double copies of the A allele are linked to a strong predisposition for heavy smoking and a 1.8x higher risk of lung cancer. The blunted receptor response makes nicotine highly addictive and makes quitting smoking significantly more challenging.
What this genotype means: Significantly blunted sensitivity to nicotine; Strong tendency toward heavy smoking and high daily cigarette consumption; Approximately 1.8x higher risk of lung cancer.
Sample genotype (not yours): G/A
Moderately Increased Nicotine Dependence and Lung Cancer Risk
One copy of the A allele is associated with a moderate increase in nicotine dependence and a 1.3x higher risk of lung cancer. This genetic variant blunts receptor sensitivity, often leading to smoking more heavily to achieve the same satisfaction.
What this genotype means: Moderately reduced sensitivity to nicotine; Tendency to smoke more cigarettes per day to satisfy cravings; Approximately 1.3x higher risk of lung cancer.
Gene function and biological role
Gene Function: Nicotinic acetylcholine receptor subunit alpha 3, encoded by the CHRNA3 gene, is a critical component of the brain's reward pathway [1]. These receptors bind nicotine and modulate the release of neurotransmitters like dopamine, directly influencing how the brain experiences reward and reinforcement [2]. CHRNA3 is part of a tightly linked gene cluster on chromosome 15 that also includes CHRNA5 and CHRNB4, which together regulate physical responses to nicotine [1]. Variations in this cluster are heavily implicated in the severity of nicotine dependence and the quantity of tobacco consumed [3].
Variant Impact: A synonymous change at rs1051730 does not alter the encoded amino acid sequence, but it serves as an exceptionally strong genetic marker for a functional variant nearby [4]. It is in almost perfect linkage disequilibrium with rs16969968, a missense mutation in the neighboring CHRNA5 gene that alters receptor sensitivity to nicotine [5]. Because of this tight genetic link, rs1051730 acts as a proxy for altered receptor function, directly correlating with how much nicotine is required to satisfy the brain's craving [6]. This genetic marker is widely recognized as one of the most significant genetic predictors of smoking intensity and related health outcomes [3].
Key Insight: This genetic variant does not change the protein structure itself, but acts as a powerful proxy for a nearby mutation that blunts the brain's sensitivity to nicotine, prompting heavier smoking to achieve the same buzz.
Location: CHRNA3. Chromosome 15 · 15q25.1 · 78.6 Mb
Estimated prevalence by population
Global 56.2%; European 42.5%; African 77.7%; East Asian 93.6%; South Asian 60.8%; Americas 58.7%; Ashkenazi 38.4%; Finnish 45.4%; Middle Eastern 34.6%; Amish 33.7%.
Estimated GG genotype frequency.
Global 35.9%; European 45.4%; African 20.9%; East Asian 6.3%; South Asian 34.4%; Americas 35.8%; Ashkenazi 47.1%; Finnish 43.9%; Middle Eastern 48.4%; Amish 48.7%.
Estimated GA genotype frequency.
Global 7.8%; European 12.1%; African 1.4%; East Asian 0.1%; South Asian 4.9%; Americas 5.5%; Ashkenazi 14.4%; Finnish 10.6%; Middle Eastern 16.9%; Amish 17.6%.
Estimated AA genotype frequency.
Showing effects for G/G genotype
Neurology & Mental Health
Addiction & Reward
Nicotine Dependence. Evidence: 7/10. Source: PMID 18385739. Typical Risk.
Cigarettes Per Day. Evidence: 8/10. Source: PMID 30617275. Typical Amount.
Cancer & Oncology
Lung Cancer
Lung Cancer. Evidence: 8/10. Source: PMID 18385738. Typical Risk.
Cardiovascular & Metabolic
Vascular Health & Aneurysm
Peripheral Artery Disease. Evidence: 8/10. Source: PMID 34601942. Typical Risk.
Organ Systems
Respiratory Health
Lung Function. Evidence: 9/10. Source: PMID 26634245. Typical Function.
Showing effects for A/A genotype
Nicotine Dependence. Evidence: 7/10. Source: PMID 18385739. Highest Risk.
Cigarettes Per Day. Evidence: 8/10. Source: PMID 30617275. Significantly Elevated.
Lung Cancer. Evidence: 8/10. Source: PMID 18385738. ~1.8x Increased Risk.
Peripheral Artery Disease. Evidence: 8/10. Source: PMID 34601942. Increased Risk.
Lung Function. Evidence: 9/10. Source: PMID 26634245. Reduced Function.
Showing effects for G/A genotype
Nicotine Dependence. Evidence: 7/10. Source: PMID 18385739. Increased Risk.
Cigarettes Per Day. Evidence: 8/10. Source: PMID 30617275. Slightly Elevated.
Lung Cancer. Evidence: 8/10. Source: PMID 18385738. ~1.3x Increased Risk.
Peripheral Artery Disease. Evidence: 8/10. Source: PMID 34601942. Slightly Increased.
Lung Function. Evidence: 9/10. Source: PMID 26634245. Slightly Reduced.
What this genotype means for the people who carry it
Sample genotype: GG (Homozygous)
Two copies of the G allele mean your nicotinic acetylcholine receptors function with typical sensitivity [1]. In the brain's reward pathway, these receptors respond normally to standard levels of nicotine, meaning you do not have a genetically driven urge to smoke excessively to feel satisfied [2]. Consequently, if you smoke, you are likely to consume a lower average number of cigarettes per day than individuals carrying the A allele [3]. This typical smoking behavior directly translates to a lower lifetime exposure to tobacco carcinogens, resulting in a standard baseline risk for lung cancer and peripheral arterial disease [4]. Furthermore, your lung function is expected to remain within the typical range for your age and lifestyle [5]. While avoiding smoking is still the single best way to protect your lungs, your genetics do not add an extra layer of risk. Your body's natural response to alcohol is also likely to be typical, meaning you feel its effects normally. This standard sensitivity helps prevent the subtle genetic nudge toward overconsumption seen in other genotypes.
Typical sensitivity to nicotine; Lower average cigarettes smoked per day if a smoker; Standard baseline risk for lung cancer and PAD.
Sample genotype: AA (Homozygous)
Two copies of the A allele significantly blunt the sensitivity of nicotinic acetylcholine receptors in the brain [1]. To overcome this reduced sensitivity and trigger a normal release of dopamine, individuals with this genotype typically smoke much more heavily [2]. This drive to consume more cigarettes per day makes nicotine highly addictive and makes quitting smoking exceptionally difficult [3]. The resulting high exposure to tobacco smoke is directly linked to a 1.8-fold increase in the risk of developing lung cancer [4]. Furthermore, this genotype is associated with an elevated risk of peripheral arterial disease and accelerated decline in lung function [5]. Because these risks are heavily dependent on tobacco exposure, avoiding smoking entirely or using targeted nicotine replacement therapies is highly effective for protecting your long-term health. There is also a known link between this genotype and a reduced immediate physical response to alcohol, which can inadvertently increase the risk of overdrinking. Recognizing these biological patterns allows for highly personalized prevention and wellness strategies.
Significantly blunted sensitivity to nicotine; Strong tendency toward heavy smoking and high daily cigarette consumption; Approximately 1.8x higher risk of lung cancer.
Sample genotype: GA (Heterozygous)
An inherited single copy of the A allele alters the sensitivity of nicotinic receptors in the brain's reward center [1]. Because the receptors are slightly less responsive, individuals with this genotype often require more nicotine to experience the same rewarding effects, making it easier to develop a stronger dependence [2]. If you smoke, you are genetically predisposed to smoke more cigarettes per day to satisfy cravings [3]. This increased tobacco exposure is the primary driver behind a moderately elevated risk of developing lung cancer, estimated at approximately 1.3 times the baseline risk [4]. Additionally, this genotype is associated with a slightly higher risk of peripheral arterial disease and a subtle reduction in overall lung function over time [5]. Taking proactive steps to avoid smoking or utilizing structured cessation support can significantly mitigate these genetically elevated risks. Understanding this genetic tendency can empower you to make informed lifestyle choices. Your response to other substances like alcohol may also be slightly altered, though to a lesser degree than double-copy carriers.
Moderately reduced sensitivity to nicotine; Tendency to smoke more cigarettes per day to satisfy cravings; Approximately 1.3x higher risk of lung cancer.
Variants with shared genetic architecture
rs8040868 · CHRNA3 Gene · Chr 15 · Lung Health and Smoking Risk
rs12914385 · CHRNA3 Gene · Chr 15 · Lung and Respiratory Health
rs8042374 · CHRNA3 Gene · Chr 15 · Lung Cancer Risk
Association of the CHRNA5-A3-B4 gene cluster with heaviness of smoking: a meta-analysis.
A variant associated with nicotine dependence, lung cancer and peripheral arterial disease.
Content updated August 2026.
ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.
Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026
Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com